The Brighterside of News on MSN2h
Weight-loss drug Semaglutide could significantly reduce the risk of heart attacks
A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
Four things you need to know about Medicare drug costs and coverage in 2025
In 2025, everyone enrolled in Part D will have their annual out-of-pocket drug costs capped at $2,000. In future years, that cap will rise in step with the rate of change in Part D costs.